Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates approximately 500 ophthalmic hospitals in mainland China, 86 ophthalmic hospitals in Europe, 1 ophthalmic hospital in the United States, 7 ophthalmic hospitals in Hong Kong, and 12 ophthalmic hospitals in Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.
P/E ratio for Aier Eye Hospital Group Co., Ltd. (300015.SZ)
P/E ratio as of 2023: 41.97
According to Aier Eye Hospital Group Co., Ltd.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 41.97. At the end of 2022 the company had a P/E ratio of 87.38.
P/E ratio history for Aier Eye Hospital Group Co., Ltd. from 2006 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 41.97 |
| 2022 | 87.38 |
| 2021 | 97.54 |
| 2020 | 177.01 |
| 2019 | 88.50 |
| 2018 | 79.59 |
| 2017 | 81.14 |
| 2016 | 41.48 |
| 2015 | 55.21 |
| 2014 | 44.26 |
| 2013 | 46.64 |
| 2012 | 30.40 |
| 2011 | 47.87 |
| 2010 | 76.09 |
| 2009 | 42.62 |
| 2008 | 65.39 |
| 2007 | 97.28 |
| 2006 | 249.29 |